A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies
Published in Journal of Clinical Pathology, October 2018
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients